Wang, X.; Zeng, H.; Zhu, X.; Xu, D.; Tian, Q.; Wang, C.; Zhao, L.; Zhao, J.; Miao, M.; Wu, X.
TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment. Molecules 2022, 27, 3686.
https://doi.org/10.3390/molecules27123686
AMA Style
Wang X, Zeng H, Zhu X, Xu D, Tian Q, Wang C, Zhao L, Zhao J, Miao M, Wu X.
TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment. Molecules. 2022; 27(12):3686.
https://doi.org/10.3390/molecules27123686
Chicago/Turabian Style
Wang, Xinlong, Huahui Zeng, Xin Zhu, Duanjie Xu, Qikang Tian, Can Wang, Lingzhou Zhao, Junwei Zhao, Mingsan Miao, and Xiangxiang Wu.
2022. "TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment" Molecules 27, no. 12: 3686.
https://doi.org/10.3390/molecules27123686
APA Style
Wang, X., Zeng, H., Zhu, X., Xu, D., Tian, Q., Wang, C., Zhao, L., Zhao, J., Miao, M., & Wu, X.
(2022). TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment. Molecules, 27(12), 3686.
https://doi.org/10.3390/molecules27123686